戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oduction defects that frequently have severe neurological manifestations.
2 was met with increased reports of associated neurological manifestations.
3 iciency disorders, characterized by variable neurological manifestations.
4  in patients presenting with fever and acute neurological manifestations.
5 were reviewed to identify those with primary neurological manifestations.
6 y recurrent hemiplegic episodes and distinct neurological manifestations.
7 oth males and females, and in some patients, neurological manifestations.
8 hen synucleinopathy occurs in the absence of neurological manifestations.
9 euroserpin inclusion bodies but with various neurological manifestations.
10  effects of GD, the lack of efficacy for the neurological manifestations, along with the considerable
11                    This Review discusses the neurological manifestations and emerging therapies for t
12 ar Purkinje cell loss, slowed progression of neurological manifestations, and increased lifespan in m
13 cians are attempting to further characterise neurological manifestations associated with mutations in
14 utations in TSC1 or TSC2 may lead to certain neurological manifestations associated with the disease.
15 ecal HPbetaCD to participants with NPC1 with neurological manifestation at the National Institutes of
16 ns characterized by hemorrhagic fever and/or neurological manifestations, constituting public health
17                                              Neurological manifestations ensue from primary loss of d
18 gen targets that plausibly explained several neurological manifestations; for example, P/Q-type Ca(2+
19                                              Neurological manifestations in 95 patients were (in decr
20                                     Although neurological manifestations in patients with established
21 uidelines that, for the first time, consider neurological manifestations in the clinical case classif
22                  Prevalence of non-cognitive neurological manifestations in the DIAN-OBS cohort was l
23 ic purpura (TTP) is a syndrome with numerous neurological manifestations including altered mental sta
24 elopment of hamartomas in various organs and neurological manifestations including epilepsy, intellec
25                              Its most severe neurological manifestation is cerebral adrenoleukodystro
26 assess if therapy aimed at the prevention of neurological manifestations is warranted.
27          Clinicoradiological features of its neurological manifestations, its prognosis, and the freq
28  and progressive clinical features and other neurological manifestations, linked with magnetic resona
29                           Additional diverse neurological manifestations may dominate the clinical pi
30  (n = 98); (3) MG plus additional autoimmune neurological manifestations (n = 26); and (4) neurologic
31                 Sydenham chorea is the major neurological manifestation of ARF but its pathogenesis h
32                      Ataxia is the commonest neurological manifestation of coeliac disease.
33             Lyme neuroborreliosis (LNB), the neurological manifestation of systemic infection with th
34 eficiency of research and information on the neurological manifestation of the disease.
35  enzyme replacement therapy to treat the non-neurological manifestations of ASMD.
36                                              Neurological manifestations of complex humanitarian emer
37 t appear to have significant benefits on the neurological manifestations of GD3.
38 n this Personal View, we review the range of neurological manifestations of gluten sensitivity and di
39                                              Neurological manifestations of HCV infection include fat
40     This has had a significant impact on the neurological manifestations of HIV infection, posing new
41                  In addition to the hallmark neurological manifestations of Huntington's disease (HD)
42                         We aimed to describe neurological manifestations of influenza in adults and c
43 scribed a cohort of adults and children with neurological manifestations of influenza.
44                                              Neurological manifestations of Lyme disease are usually
45                                              Neurological manifestations of Lyme disease in humans ar
46            Development of treatments for the neurological manifestations of MPS has been hindered by
47 s and neurons allowed us to link a subset of neurological manifestations of MSD to astrocyte dysfunct
48                                          The neurological manifestations of sarcoidosis, which occur
49                             Amongst the many neurological manifestations of SLE, cognitive impairment
50 system of patients with KSS accounts for the neurological manifestations of the disease.
51            No treatment is available for the neurological manifestations of the disease.
52 multi-centre international study focusing on neurological manifestations of the largest cohort of Les
53 ing some pathogenic conundrums regarding the neurological manifestations of the respiratory chain def
54  combined with immunotherapy can improve the neurological manifestations of these patients.
55 hout and were most frequent in patients with neurological manifestations other than or in addition to
56 cism was associated with milder disease, yet neurological manifestations persisted in 3 individuals.
57 w that mice carrying this mutation developed neurological manifestations similar to those of human pa
58 gnitive disorder (HAND) remains an important neurological manifestation that adversely affects a pati
59     Recent reports have also indicated other neurological manifestations to be associated with ZIKV,
60  acid, the parent compound linked with human neurological manifestations was subjected to toxicologic

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。